Author:
Ceriotti Ferruccio,Fernandez-Calle Pilar,Klee George G.,Nordin Gunnar,Sandberg Sverre,Streichert Thomas,Vives-Corrons Joan-Lluis,Panteghini Mauro
Abstract
AbstractThis paper, prepared by the EFLM Task and Finish Group on Allocation of laboratory tests to different models for performance specifications (TFG-DM), is dealing with criteria for allocating measurands to the different models for analytical performance specifications (APS) recognized in the 1st EFLM Strategic Conference Consensus Statement. Model 1, based on the effect of APS on clinical outcome, is the model of choice for measurands that have a central role in the decision-making of a specific disease or clinical situation and where cut-off/decision limits are established for either diagnosing, screening or monitoring. Total cholesterol, glucose, HbA
Subject
Biochemistry, medical,Clinical Biochemistry,General Medicine
Reference58 articles.
1. A systematic review of data on biological variation for alanine aminotransferase, aspartate aminotransferase and γ-glutamyl transferase;Clin Chem Lab Med,2013
2. Setting analytical performance specifications based on outcome studies – is it possible?;Clin Chem Lab Med,2015
3. Clinical assessment of hemoglobin values by general practitioners related to analytical and biological variation. A study based on case stories;Scand J Clin Lab Invest,1991
4. Reliability of biological variation data available in an online database: need for improvement;Clin Chem Lab Med,2015
5. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines;Circulation,2014
Cited by
124 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献